RESUMO
Event-related potentials induced by somatosensory and after auditory stimulation or bilateral somatosensory stimulation in young adults were studied, aiming to evaluate interactions of cognitive processing of somatosensory and auditory information. In experiment 1, event-related potentials were elicited by four stimulus conditions which were randomly presented with an interstimulus interval of 20 +/- 3 milliseconds: electric stimuli delivered to the right median nerve (Con 1), auditory stimuli delivered to both ears (Con 2), electric and subsequent auditory stimuli (Con 3), and electric stimuli delivered to the bilateral median nerve (Con 4). In experiment 2, Con 2 was changed to electric stimulation of the left median nerve. The subtraction of grand averaged event-related potentials of Con 1 and Con 2 from those of Con 3 demonstrated a positive-negative peak complex with a positive peak at approximately 165 to 170 milliseconds after stimuli and a negative peak with a mean latency of 372 milliseconds in experiment 1. In experiment 2, the subtraction of event-related potentials in Con 1 and 2 from those in Con 4 revealed positive and negative peaks resembling those in experiment 1, but the distribution or latencies of the peaks differed from those in experiment 1. We speculate that the subtracted positive and negative peaks reflect different cognitive processing of bimodal and bifocal sensory information.
Assuntos
Córtex Auditivo/fisiologia , Cognição/fisiologia , Potenciais Evocados Auditivos/fisiologia , Potenciais Somatossensoriais Evocados/fisiologia , Córtex Somatossensorial/fisiologia , Estimulação Acústica/métodos , Adolescente , Adulto , Análise de Variância , Mapeamento Encefálico , Estimulação Elétrica , Eletroencefalografia/métodos , Feminino , Humanos , Masculino , Tempo de Reação/fisiologia , Análise e Desempenho de TarefasRESUMO
OBJECTIVE: Zinc supplementation has been shown to contribute to inhibition of liver fibrosis and improvement in hepatic encephalopathy. However, little is known about the anti-inflammatory effect of zinc on hepatitis C virus (HCV)-related chronic liver disease (CLD). We therefore examined the effects of zinc administration on inflammatory activity and fibrosis in the liver of patients with HCV-related CLD. MATERIAL AND METHODS: Polaprezinc, a complex of zinc and l-carnosine, was administrated at 225 mg/day for 6 months to 14 patients with HCV-related CLD, in addition to their ongoing prescriptions. Peripheral blood cell counts, liver-related biochemical parameters, serological markers for liver fibrosis, HCV-RNA loads, and serum levels of zinc and ferritin were evaluated before and after zinc administration. RESULTS: Serum zinc concentrations were positively correlated with hepatic reserve before zinc supplementation. A significant increase in serum zinc level was observed after zinc supplementation (64+/-15 versus 78+/-26 mg/dl, p=0.0156). Treatment with polaprezinc significantly decreased serum aminotransferase levels (aspartate aminotransferase (AST): 92+/-33 versus 63+/-23 IU/l, p=0.0004; alanine aminotransferase (ALT): 106+/-43 versus 65+/-32 IU/l, p=0.0002), whereas alkaline phosphatase levels were significantly increased (305+/-117 versus 337+/-118 U/l, p=0.0020). Serum ferritin levels were significantly decreased by treatment with polaprezinc (158+/-141 versus 101+/-80 ng/ml, p=0.0117). The reduction rate of ALT levels by polaprezinc was positively correlated with that of ferritin (r(2)=0.536, p=0.0389). There was a tendency toward a decrease in serum type IV collagen 7S levels after treatment with polaprezinc. However, administration of polaprezinc did not affect peripheral blood cell counts, other liver function tests, or HCV-RNA loads. CONCLUSIONS: These findings suggest that polaprezinc exerts an anti-inflammatory effect on the liver in patients with HCV-related CLD by reducing iron overload.
Assuntos
Anti-Inflamatórios/administração & dosagem , Carnosina/análogos & derivados , Hepatite C Crônica/complicações , Cirrose Hepática/tratamento farmacológico , Compostos Organometálicos/administração & dosagem , Administração Oral , Adulto , Idoso , Biomarcadores/sangue , Carnosina/administração & dosagem , Colágeno Tipo IV/sangue , Cobre/sangue , Feminino , Hepacivirus/genética , Hepatite C Crônica/sangue , Hepatite C Crônica/enzimologia , Humanos , Ácido Hialurônico/sangue , Ferro/sangue , Cirrose Hepática/sangue , Cirrose Hepática/enzimologia , Testes de Função Hepática , Masculino , Pessoa de Meia-Idade , Contagem de Plaquetas , Albumina Sérica , Fatores de Tempo , Zinco/sangue , Compostos de Zinco/administração & dosagemRESUMO
We report a case of hypovascular advanced hepa-tocellular carcinoma (HCC) successfully treated with a novel combination therapy of percutaneous ethanol-lipiodol injection (PELI) and intervention radiology (IVR), lipiodol-targetting IVR (Lipi-IVR). The present case had a hypovascular HCC (3 cm in diameter) located in the S6 region of the liver. Although the tumor was not detectable at all by both of early and late phase of helical dynamic computed tomography (CT), it could be detected by ultrasonography (US) as a low echoic space occupying lesion (SOL) beside the gallbladder and right kidney. Serum levels of alpha fetoprotein (AFP) and AFP-L3 were extremely high. Combination therapy of PELI, firstly reported in our department, and IVR (PELI and IVR, lipiodol-targetting IVR) was performed twice for the treatment. PELI could effectively visualize the location of the tumor for IVR treatment and show the presence of a thin blood vessel branching from the right hepatic artery flowing into the lipiodol deposit. After treatment, the serum levels of AFP and AFP-L3 were rapidly decreased to normal and maintained for more than eight months. Thus, this case expressing the tremendous effect might give us insight into the effectiveness of the novel combination therapy of PELI and IVR for the treatment of hypovascular HCC.
Assuntos
Carcinoma Hepatocelular/radioterapia , Meios de Contraste/uso terapêutico , Óleo Iodado/uso terapêutico , Neoplasias Hepáticas/radioterapia , Radiologia Intervencionista/métodos , Antimetabólitos Antineoplásicos/uso terapêutico , Carcinoma Hepatocelular/tratamento farmacológico , Terapia Combinada , Feminino , Fluoruracila/uso terapêutico , Humanos , Neoplasias Hepáticas/tratamento farmacológico , Pessoa de Meia-IdadeRESUMO
We report a case of large-size hepatocellular carcinoma (HCC) successfully treated with transarterial chemoembolization (TACE) followed by the combination therapy of percutaneous ethanol-lipiodol injection and radiofrequency ablation (PELI-RFA) and percutaneous ethanol-lipiodol injection (PELI) therapy. In the present case, the patient had a large-size advanced HCC, 7 cm in diameter, located in the S8 region of the liver. In addition, the hepatic reserve of the patient was severely poor. In order not to impair the poor hepatic reserve, we chose PELI-RFA and PELI, originally developed in our department and reported as milder treatment modalities than others. After TACE , PELI-RFA and PELI were performed several times, the HCC was totally destroyed and early enhancement shown by helical dynamic computed tomography disappeared completely after treatment. The hepatic reserve of the patient was not impaired by the series of treatments. Serum levels of tumor markers, alpha-fetoprotein and Des-gamma-carboxy prothrombin, were rapidly decreased to almost normal levels. PELI-RFA and PELI may be effective for the treatment of large-size HCC of patients with poor hepatic reserve.
Assuntos
Carcinoma Hepatocelular/terapia , Ablação por Cateter/métodos , Quimioembolização Terapêutica/métodos , Etanol/administração & dosagem , Óleo Iodado/administração & dosagem , Neoplasias Hepáticas/terapia , Idoso , Carcinoma Hepatocelular/irrigação sanguínea , Terapia Combinada , Feminino , Humanos , Neoplasias Hepáticas/irrigação sanguíneaRESUMO
Percutaneous radiofrequency ablation (RFA) is able to destroy hepatocellular carcinoma (HCC) in a few sessions without major complications. We have previously shown that not only the combined use of percutaneous ethanol injection and RFA (PEI-RFA) but also injection of mixture of ethanol and lipiodol (PELIT) was useful for the treatment of HCC. In the present study, we further developed the combined use of PELIT and RFA through percutaneous or laparoscopic approach (PELI-RFA or LELI-RFA) and evaluated its usefulness. Nineteen nodules in 18 cases were treated with PELI-RFA or LELI-RFA. In the cases treated with LELI-RFA, no bleeding and no spilling milky fluid containing tumor cells were observed from the surface of ablated tumors. In the cases sufficiently treated with PELI-RFA or LELI-RFA, the mixture of ethanol and lipiodol was accumulated in the entire region of the tumor and low-density area was observed around the lipiodol deposit by computed tomography (CT). These delineations of coagulated area were helpful to evaluate the precise area of safety margin around the tumor treated with PELI-RFA or LELI-RFA. Furthermore, the total volume of coagulated necrosis significantly and positively correlated with the product of energy requirement for ablation and the volume of ethanol injected by PELI-RFA or LELI-RFA. Among the cases treated with PELI-RFA or LELI-RFA, local recurrence emerged only in one case in whom enough safety margin could not be achieved by PELI-RFA. Therefore, it is critical to evaluate whether enough safety margin could be obtained with RFA therapy, and PELI-RFA and LELI-RFA are helpful in visualizing the safety margin area.
Assuntos
Meios de Contraste/administração & dosagem , Etanol/administração & dosagem , Óleo Iodado/administração & dosagem , Neoplasias Hepáticas/cirurgia , Recidiva Local de Neoplasia , Ablação por Cateter , Feminino , Humanos , Laparoscopia , Masculino , Pessoa de Meia-Idade , Tomografia Computadorizada por Raios X , Resultado do TratamentoRESUMO
Radiofrequency ablation (RFA) therapy is of great significance in the treatment of hepatocellular carcinoma (HCC) or metastatic liver tumors. RFA is able to achieve widely coagulated necrosis in a few sessions without major complications. However, HCC cases exist that are resistant to RFA therapy for several reasons. In the present study, we performed injection of the mixture of ethanol and lipiodol (percutaneous ethanol-lipiodol injection therapy: PELIT) for HCCs that lacked clear visuality of the entire shape of the tumor by ultrasonography (US) or computed tomography (CT), or that were difficult to treat with RFA alone due to their locations in the liver or due to severe liver dysfunction of the patients. Local recurrence rates of HCC treated with PELIT were shown to be low in patients followed up for at least 4 months. In all patients treated with PELIT, lipiodol was accumulated in the entire region of the tumor after several trials of PELIT and the accumulation was kept for many months. The biopsy examination from the tumor treated with PELIT showed that HCC cells were totally destroyed by the PELIT. Although RFA therapy serves as a central role for the treatment of HCCs, PELIT, considered to be milder therapy, is likely to be important as a supportive treatment for HCCs and useful for the treatment of HCCs that are difficult to treat with RFA.
Assuntos
Administração Cutânea , Carcinoma Hepatocelular/tratamento farmacológico , Etanol/uso terapêutico , Óleo Iodado/uso terapêutico , Neoplasias Hepáticas/tratamento farmacológico , Idoso , Biópsia , Ablação por Cateter , Ensaios Clínicos como Assunto , Meios de Contraste/administração & dosagem , Meios de Contraste/uso terapêutico , Etanol/administração & dosagem , Feminino , Humanos , Injeções Intralesionais , Óleo Iodado/administração & dosagem , Fígado/patologia , Masculino , Pessoa de Meia-Idade , Necrose , Metástase Neoplásica , Tomografia Computadorizada por Raios X , UltrassonografiaRESUMO
It has been suggested that both extracellular matrix (ECM) remodeling and persistent hepatocyte injury play important roles in liver carcinogenesis process. It is, however, still controversial which factor plays a predominant role. The aim of the present study was to examine the role of each factor in the liver enzyme-altered preneoplastic lesions, focusing on the relationship between the hepatocyte injury and fibrosis extension. The effects of two similar herbal medicines (Sho-saiko-to and Saiko-keishi-to: TJ-9 and TJ-10, respectively) were elucidated on the hepatocyte injury, fibrosis and preneoplastic lesions development using a choline-deficient-L-amino acid-defined (CDAA) diet rat liver carcinogenesis model. TJ-9 prevented fibrosis and glutathione S-transferase placental form (GST-P)-positive preneoplastic lesion development without reducing the hepatocyte injury as indicated by the serum markers. TJ-10 significantly protected against the hepatocyte injury. However, it did not exert any inhibitory effect on fibrosis and the development of preneoplastic lesions. Our in vitro study revealed that TJ-9 markedly suppressed the hepatic stellate cell activation whereas TJ-10 did not. These results suggested that the ECM remodeling plays a more important role than the persistent hepatocyte injury in the liver enzyme-altered preneoplastic lesion development in the rat.
Assuntos
Carcinoma Hepatocelular/metabolismo , Matriz Extracelular/fisiologia , Neoplasias Hepáticas/metabolismo , Fígado/metabolismo , Aminoácidos/farmacologia , Animais , Biomarcadores/sangue , Carcinoma Hepatocelular/patologia , Carcinoma Hepatocelular/prevenção & controle , Deficiência de Colina/complicações , Dieta , Medicamentos de Ervas Chinesas/farmacologia , Glutationa Transferase/metabolismo , Hidroxiprolina/metabolismo , Fígado/efeitos dos fármacos , Cirrose Hepática/enzimologia , Cirrose Hepática/prevenção & controle , Neoplasias Hepáticas/patologia , Neoplasias Hepáticas/prevenção & controle , Masculino , Lesões Pré-Cancerosas/metabolismo , Lesões Pré-Cancerosas/prevenção & controle , RNA Mensageiro/análise , Ratos , Ratos Endogâmicos F344RESUMO
We studied the effects of 0.2 Hz repetitive transcranial magnetic stimulation (rTMS) successively performed 6 times for 2 weeks in 12 patients with idiopathic Parkinson's disease (PD). Ten patients received rTMS to the bilateral frontal cortex (frontal rTMS) and six patients received rTMS to the bilateral occipital cortex (occipital rTMS). Before and after rTMS, we evaluated regional cerebral blood flow (rCBF) using 99m-Tc-ECD single photon emission computed tomography (SPECT) and clinical tests. In an analysis with statistic parametric mapping, both frontal and occipital rTMS reduced rCBF in the cortical areas around the stimulated site. The activities of daily living (ADL) and motor scores of Unified Parkinson's Disease Rating Scale (UPDRS), pronation-supination movements, and buttoning up significantly improved after frontal rTMS than before it, while occipital rTMS had no significant effects in clinical tests.The findings of the present study suggest that successive 0.2 Hz rTMS has outlasting inhibitory effects on neuronal activity around the stimulated cortical areas. Because there were no significant relations between improved clinical tests and reduced rCBF, we speculate that the indirect effects of 0.2 Hz rTMS on subcortical structures are related to improved parkinsonian symptoms. Further studies recruiting large numbers of subjects are required to confirm the efficacy of 0.2 Hz rTMS on PD.